• Skip to primary navigation
  • Skip to main content
  • Skip to footer

MCN Solutions

  • Solutions
        • For Healthcare
        • Policy Manager
        • Policy Library
        • StayAlert!
        • StayAlert! Plus
        • eLearning
        • Contract Manager
        • For Higher Education
        • Higher Education Policy Manager
        • Contract Manager
        • For Business
        • Policy Manager
        • Contract Manager
        • eLearning for Business
  • About Us
  • Resources
    • Blog
    • Product Sheets
    • E-book
    • Case Studies
    • Videos
    • StayAlert! Login
  • Contact

Schedule a Demo

Site Map

Pages

  • About Us
  • Blog
  • Careers
  • Case Studies
  • Christie Clinic Case Study
  • Contact
  • Contract Manager
  • Disclaimer
  • Download Contract Manager
  • Download eLearning
  • DownLoad Policy Library
  • Download Policy Manager
  • Download StayAlert
  • Download StayAlert Plus
  • E-book
  • eLearning
  • eLearning for Business
  • Emory Case Study
  • For Business
  • For Healthcare
  • For Higher Education
  • HealthAlliance Case Study
  • Higher Education Policy Management Software
  • Home
  • Meritus Medical Center Case Study
  • Our Partners
  • Personal Data Request
  • Policy & Procedure Library
  • Policy Manager
  • Poplar Bluff Case Study
  • Privacy Policy
  • Product Sheets
  • Resources
  • Schedule a Demo
  • StayAlert! Plus
  • StayAlert! Regulatory Notifications
  • Videos
  • Web Accessibility
  • Web-based Learning
  • White Papers

Posts by category

  • Category: Contract Management
    • How to Reduce Risk With Contract and Risk Management
  • Category: Document Management
    • Healthcare Document Management Software
    • Policy Management Software As a Part of Risk Management in Healthcare
  • Category: Education
    • Staff Education as a Business Priority
    • Importance of Continuing Staff Education
    • How Staff Education in Healthcare Drives Excellence
  • Category: General
    • Corporate Compliance and Ethics Week: Why It Matters for Your Organization
  • Category: Healthcare
    • CMS Requirements for Director of Nursing Roles
    • Review of a Hospital’s Diet Orders
    • Risks of Ineffective Policy Management
    • Choosing the Right Policy Management Software for Healthcare
    • Overcoming Challenges in Public Health Policy Implementation
    • Policy Management Challenges and Benefits
    • Enhancing Patient Safety Through Better Care Coordination
    • Medicare Swing Bed Rules and Regulations for CAHs
    • Exploring the Difference Between Nursing Procedures and Policies
    • Nurse Appreciation: The Quiet Heroes We Are Thankful for This Thanksgiving
    • Regulatory Change Management: 5 Essential Tips for Staying Ahead
    • Elevating Patient Safety: The Crucial Role of Policy Management
    • Hero Women Rising: A Chance to Double Your Impact
    • Elevating Patient Safety: The Crucial Role of Policy Management
    • January is Human Trafficking Prevention Month
    • Strategies for Promoting Ethical Behavior in Healthcare Compliance
    • The Role of Healthcare Policy and Procedure Management Software
    • The Essential Components of an Effective Healthcare Compliance Program
    • Best Ways to Solve Policy Management Challenges in Healthcare
    • Navigating Policy Challenges in Healthcare: Centralized Management for Compliance and Efficiency
    • Staying Up-to-Date with Compliance Requirements with Healthcare Policy Management Software
    • Maximizing Efficiency with Contract Management Software
    • How to Utilize Policy Management Software to Improve Quality of Care
    • Effective Strategies for Enhancing Governance, Risk, and Compliance
    • Streamline Your Nursing Policy Review Process for Improved Efficiency
    • Patient Safety Awareness Week
    • How to Effectively Introduce Nursing Policies To Staff
    • Using Nursing Policy Management to Ensure Quality Care
    • Sepsis Survivors Week
    • MCN Healthcare’s Exemplary Customer Experience
    • Hero Women Rising and MCN Foundation
    • A Holistic Approach to Success
    • Exceptional Customer Support Leads to Greater Adoption, Use, and Value of Policy Management Software
    • Policy Management Software Should Make Your Job Easier, Not Harder
    • Why You Need Policy Automation in the First Place
    • National Time Out Day
    • Patient Safety Awareness Week – March 13 – 19, 2022
    • Unit Manager’s Role in the Policy Process
    • Global Handwashing Day – October 15, 2021
    • World Mental Health Day – October 10, 2021
    • Breast Cancer Awareness Month
    • Policies, Protocols, and Guidelines
    • World Patient Safety Day – September 7, 2021
    • World Suicide Prevention Day | September 10, 2021
    • MCN Foundation and Ethiopian Education Foundation Collaborate to Support Students
    • The Impact of Leadership Culture on Achieving Effective Clinical Practice Change
    • World Health Day – April 7, 2021
    • World Antimicrobial Awareness Week November 18-24, 2020
    • Organizational Risk Related to Poor Document Control and Policy Management
    • International Day of the Girl – October 11, 2020
    • October is Breast Cancer Awareness Month
    • September is Sepsis Awareness Month
    • Sepsis – Information for Health Care Professionals
    • Sepsis Heroes Gala
    • September 10th is World Suicide Prevention Day
    • Risk and Policy Management
    • Heroes Health Mental Wellness App
    • StayAlert! to Stay Compliant
    • An Update of Mental Health Initiatives During Mental Health Awareness Month
    • Nurses Make a Difference
    • Heroes
    • New OCR Settlement Highlights Challenges of Implementing COVID-19 Triage Policies
    • Mindfulness in the Midst of a Pandemic
    • Take a Minute to say THANK YOU – World Health Day 2020
    • COVID-19 and Sepsis
    • Free 90-day StayAlert! Trial
    • CMS Releases Telehealth and Telemedicine Tool Kit for Long-Term Care Nursing Homes
    • World TB Day – It’s Time to End TB!
    • Identifying Human Trafficking Victims
    • Patient Safety Awareness Week – Resources to Help Keep Patients Safe
    • Happy International Women’s Day!
    • So Many Policies and Procedures, So Little Time – Why Healthcare Organizations Struggle
    • HHS Reports Increase in Medicare Patients Being Hospitalized with Sepsis
    • Random Acts of Kindness Day
    • What Can Policy Management Software Do For Your Organization?
    • HHS Health Sector Cybersecurity Coordination Center (HC3) Warns of Coronavirus Themed E-mail Phishing
    • Happy New Year!
    • A Webinar Hosted by MCN Healthcare and EBSCO
    • Join Us in Celebrating Healthcare Quality Week!
    • Talking to Your Patients about Healthcare Fraud
    • October Is Breast Cancer Awareness Month!
    • GE Sponsored Webinar
    • EBSCO Information Services and MCN Healthcare Partner to Offer Healthcare Policy Expertise
    • MCN Healthcare: Coming to Orlando, FL, and Baltimore, MD!
    • Achieve Safety and Compliance in Your Healthcare Organization
    • MCN Healthcare Team Runs/Walks for Sepsis Awareness
    • MCN Policy Manager: Enhance Operational Efficiency and Meet Compliance at Your Convenience
    • Speak Up For Patient Safety – World Patient Safety Day – September 17, 2019
    • Our Story So Far— Who Is MCN?
    • September is Sepsis Awareness Month
    • CMS IPPS Final Rule Takes Aim at Antimicrobial Resistance
    • Happy National Nurses Week
    • World Tuberculosis Day 2019
    • Patient Safety Awareness Week
    • Sepsis Survivor Week
    • Are You Drowning in a Sea of Policies and Procedures?
    • Sepsis Webinar: Infection Control & Antimicrobial Stewardship
    • HHS HIPAA Settlement Reminds Hospitals to Obtain Patient Authorization Prior to Filming
    • Top 10 Challenges/Issues/Opportunities in Healthcare for 2019
    • Sepsis Alliance – It’s About Time
    • September is Sepsis Awareness Month
    • Hospitals Against Violence Day of Awareness
    • Happy Nurses Week!
    • The Nurse that I am Today
    • What Nursing Means to Me
    • Why Compliance and Risk Leaders Choose MCN Healthcare
    • How to Compare Tools for Healthcare Compliance and Regulation
    • Patient Safety Awareness Week
    • So Many Documents, So Little Time – Why Compliance Leaders Struggle
    • New CDC Training on Antibiotic Stewardship
    • Resource Guide for Measuring Compliance Program Effectiveness
    • Top 5 Challenges In Healthcare Compliance and Risk
    • One Health Day
    • To Wage War On Superbugs, FDA Clears Way For Scope With A Disposable Piece
    • Regional Anesthesia – An Alternative to Opioids
    • Why Start Enhanced Recovery After Surgery (ERAS) Protocols
    • Sepsis Awareness Month – Faces of Sepsis II
    • Sepsis Awareness Month: Faces of Sepsis
    • Save a Life by Learning the Signs of Sepsis
    • Sepsis Alliance Gala, September 14, 2017
    • September is Sepsis Awareness Month
    • The New War on Sepsis
    • Recent OIG Settlement Underscores Need for Strong EMTALA Policies
    • Solar Eclipse Safety
    • CMS Regulations and Legionella
    • HHS Releases Improved Web Tool to Highlight Recent Breaches of Health Information
    • When Wounds Won’t Heal, Therapies Spread — To the Tune of $5 Billion
    • Fire and Smoke Door Annual Testing Requirements in Health Care Occupancies – CMS Clarification
    • Fraud and Billing Mistakes Cost Medicare — And Taxpayers — Tens Of Billions Last Year
    • AUG 1 – NEW: Outpatient Rehabilitation Policy and Procedure Manual
    • AUG 1 – Rehabilitation Services Policy and Procedure Manual (Inpatient)
    • AUG 1 – OSHA Compliance Manual
    • Scope Maker Olympus Hit with $6.6 Million Verdict in Superbug Outbreak Case
    • CDC Releases Antimicrobial Stewardship Resource for Small and Critical Access Hospitals
    • Women with High-Risk Pregnancies Far More Prone to Heart Disease
    • CDC – Opioid Prescribing is Still High and Varies Widely throughout the U.S.
    • New on the Streets: Drug for Nerve Pain Boosts High for Opioid Abusers
    • Labor and Delivery Policy and Procedure Manual
    • Postpartum Policy and Procedure Manual
    • Nursery Policy and Procedure Manual
    • ‘Petya’ Cyber Attack Spreading Globally
    • HHS Issues Cyber Notice: Hidden Cobra and Microsoft Updates
    • Widow Unleashes Court Fight Against Scope Maker Olympus Over Superbug Outbreak
    • World Blood Donor Day – June 14, 2017
    • CMS Issues Proposed Revision Requirements for Long-Term Care Facilities’ Arbitration Agreements
    • Administrative Manual for Critical Access Hospitals
    • HIPAA Guidelines Policy and Procedure Manual
    • Leadership Manual
    • Report on Improving Cybersecurity in the Health Care Industry Released
    • Caring For a Loved One? Care for Yourself, Too
    • Joint Commission Clarifies Four Life Safety Code Requirements
    • Medicare Failed to Investigate Suspicious Infection Cases from 96 Hospitals
    • AHRQ Releases Toolkit to Improve Safety in Ambulatory Surgical Centers.
    • Update on International Cyber Threat to Healthcare Organizations
    • National Women’s Health Week May 14 – 20, 2017
    • Surgical Services Policy and Procedure Manual
    • Post Anesthesia Care Unit Policy and Procedure Manual
    • National Nurses Week: May 6 – 12
    • National Hospital Week May 8 – 12, The Healing Heart of Healthcare
    • MCN Healthcare Celebrates 30 Years!
    • SAVE LIVES: Clean Your Hands – Fight Antibiotic Resistance – It’s in Your Hands
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – World Malaria Day
    • Severe Shortage of Home Health Workers Robs Thousands of Proper Care
    • OIG Releases Resource Guide for Measuring Compliance Program Effectiveness
    • Another HIPAA Settlement Highlights Need for Risk Analysis of ePHI Environment
    • Medication Errors – We Know They Happen
    • Coming Full Circle, Doulas Cradle the Dying
    • The CDC Warns of Emerging Fungus in Healthcare Facilities – Candida auris
    • World Health Day – April 7, 2017
    • Dialysis Policy and Procedure Manual
    • Ambulatory Care Facility – Administrative Manual
    • Ambulatory Care Facility – Environment of Care Manual
    • By Law, Hospitals Now Must Tell Medicare Patients When Care Is ‘Observation’ Only
    • Top 10 Patient Safety Concerns for Healthcare Organizations 2017
    • Two Words Can Soothe Patients Who Have Been Harmed: We’re Sorry
    • Patient Safety Awareness Week – Policies and Procedures Matter in Patient Safety
    • Patient Safety Awareness Week – AHRQ Toolkit for LTC Facilities to Help Reduce CAUTIs
    • The Essential Role of Leadership in Developing a Safety Culture
    • 500 Cities Project – Population Health
    • Home Health Policy and Procedure Manual
    • Home Infusion Therapy Policy and Procedure Manual
    • Hospice Policy and Procedure Manual
    • HCCA’s 21st Annual Compliance Institute
    • How Long You Stay On Opioids May Depend On The Doctor You See In the E.R.
    • HCCA’S 21st Annual Compliance Institute
    • Nursing Home Antibiotic Stewardship Program
    • HCCA’s 2017 Compliance Institute
    • Joint Commission Issues Addendum to Sentinel Event, Issue 45 – Preventing Violence in the Health Care Setting
    • Life Safety and Interim Life Safety Management Manual
    • Utilities and Equipment Management Policy and Procedure Manual
    • Emergency Management and Bioterrorism Manual
    • February is American Heart Month – Changes Everyone Can Make
    • AHRQ Toolkit to Improve Safety for Mechanically Ventilated Patients
    • Antimicrobial Medications – Patient Education
    • CMS Recommendations for Providers and Suppliers for Cyber Security
    • CMS Issues Guidance on Implementing the Medicare Outpatient Observation Notice
    • Outpatient Visits for Influenza-like-Illness are Above the National Baseline: Minimize False Rapid Influenza Diagnostic Tests
    • CMS Publishes Revised Home Health Agency Conditions of Participation – Effective July 13, 2017
    • Battery-powered Mobile Medical Carts – Fire Risks
    • FDA Bans Powdered Gloves – Exam and Surgeon
    • NEW Ambulatory Infusion Center Policy and Procedure Manual
    • Anesthesia Policy and Procedure Manual
    • TJC Issues Clarification on Secure Text Messaging of Patient Care Orders
    • Long-Term Care Regulation: Enforcement of Rule Prohibiting Use of Pre-dispute Binding Arbitration Agreements is Suspended so Long as Court Ordered Injunction Remains in Effect
    • Happy Holidays from MCN Healthcare
    • CMS Releases Updated Medicare Outpatient Observation Notice (MOON)
    • New Joint Commission National Patient Safety Goal for Long Term Care Organizations
    • Decorating for the Holidays? Keep Safety in Mind
    • CMS Emergency Preparedness Requirements FAQs
    • Anesthesia Policy and Procedure Manual
    • Emergency Department Policy and Procedure Manual
    • Office of Inspector General Issues FY 2017 Work Plan
    • HAPPY THANKSGIVING
    • Thankfulness for Life: Lessons Learned as a Hospice Nurse
    • Grateful for Nurses
    • MCN Healthcare’s Policy Management Series: Policy and Procedure Development
    • Strategies for Transitioning to New Tubing Connectors
    • Anesthesia Policy and Procedure Manual
    • Pain Management Policy and Procedure Manual
    • Happy Halloween from MCN Healthcare
    • HIPAA Settlement Underscores Importance of Managing Security Risks
    • HHS’ National Action Plan to Prevent Health Care-Associated Infections – New Targets and Metrics
    • Is Your Organization Ready for Influenza Season?
    • CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
    • Central Service Policy and Procedure Manual
    • Ambulatory Surgical Center Policy and Procedure Manual
    • Surgical Services Policy and Procedure Manual
    • HHS Office for Civil Rights Issues Guidance on HIPAA and Cloud Computing
    • CDC Recommendations for Pre-Conception Counseling – Zika Virus
    • Antibiotic “Time outs”
    • MCN Employee Runs Marathons and Guides Athletes with Disabilities to the Finish Line
    • ACA Section 1557 – What Your Hospital Needs to Know
    • Last Week of Sepsis Awareness Month
    • CMS Emergency Preparedness Requirements for Hospitals – Part II
    • Advance Care Planning and Medicare
    • Sepsis Awareness Month
    • CMS Final Rule Addresses Emergency Preparedness
    • MCN Employees Cycle for a Cause on a Meaningful 9/11 Ride
    • National Suicide Prevention Week – September 5 – 11, 2016 and World Suicide Prevention Day – September 10, 2016
    • Influenza Pandemic Preparedness Guide
    • Infection Prevention and Control Manual
    • Emergency Management and Bioterrorism Manual
    • Infection Control and Toys
    • CDC Health Update – Influx of Fentanyl-laced Counterfeit Pills and Toxic Fentanyl-related Compounds
    • Changing Terminology: “Pressure Ulcer” Now to be referred to as “Pressure Injury”
    • Best Practices for Preventing Wrong Site, Wrong Procedure and Wrong Person Surgery
    • August 2016 Marks 5 Year Anniversary of National Breastfeeding Month
    • Patient Falls Top TJC’s 2Q 2016 List of Reported Sentinel Events
    • Mosquitoes – One of the Deadliest Animals in the World
    • Primary Medical Home Interdisciplinary Team
    • Home Health Policy and Procedure Manual
    • Durable and Home Medical Equipment Compliance Manual
    • Hospice Policy and Procedure Manual
    • AABB and American Red Cross Warn of Critical Blood Supply Shortage
    • CMS Releases Overall Hospital Quality Star Rating on Hospital Compare
    • The Joint Commission’s NEW Standard MM.09.01.01 – Antimicrobial Stewardship
    • Ambulatory Surgical Center Policy and Procedure Manual
    • GI Lab Policy and Procedure Manual
    • Administrative Manual for Ambulatory Care Facilities
    • How is Your Hospital Dealing with Pokémon GO?
    • HHS Announces New Actions to Combat Opioid Epidemic
    • 24th Annual Health Forum/American Hospital Association Leadership Summit, July 17 -19, 2016
    • CMS Issues Proposed Rule for Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System
    • Antimicrobial Stewardship Program
    • CMS Finalizes Rule Giving Providers and Employers Improved Access to Information for Better Patient Care
    • Accessing Investigational Drugs Outside of a Clinical Trial
    • Medicare and Medicaid Programs – Hospital and Critical Access Hospital (CAH) Changes to Promote Innovation, Flexibility, and Improvement in Patient Care – Proposed Rule
    • HIPAA Regulations and Leaving Patient Messages on Answering Machines
    • UPDATE: Hospitals will have until November to comply with new CMS Requirements addressing 2012 Life Safety Code
    • World Blood Donor Day – June 14, 2016
    • HHS Final Rule on Reducing Health Care Disparities
    • Patient and Family Communication When Unexpected Events Cause Patient Harm
    • Dr. Diane Heine – MCN Healthcare Regulatory Expert and Writer – to Speak at CIHQ’s 2016 Accreditation & Regulatory Summit
    • WHO Publishes News Release on Summer Olympics and Zika Virus
    • Evaluation of a Critical Access Hospital’s Programs
    • Administrative Manual for Critical Access Hospitals
    • Home Health Policy and Procedure Manual
    • Hospice Policy and Procedure Manual
    • Colistin-resistant mcr-1 E. coli Discovered in U.S.
    • CMS Publishes Final Rule on Fire Safety Requirements for Certain Health Care Facilities
    • NPSF Patient Safety Congress May 23-25, 2016
    • Safety of Clinical Alarm Systems
    • CDC Launches Clean Hands Count Campaign
    • Treatment Modalities and the Patient’s Treatment Plan
    • National Hospital Week, May 8 -14, 2016
    • Texting Orders
    • National Women’s Health Week May 8 – 14, 2016
    • Medical Office Policy and Procedure Manual
    • Administrative Manual for Ambulatory Care Facilities
    • Ambulatory Services Environment of Care Manual
    • National Nurses Week May 6 – 12, 2016
    • Being a Nurse
    • Joint Commission Deletes 131 Requirements for the Hospital Program
    • Homeland Security Warns Hospitals about Ransomware Risks
    • Podiatrists Completing H&Ps
    • CMS Medicare Quarterly Provider Compliance Newsletter – Billing Errors
    • National Pain Strategy Released
    • World Health Day – April 7, 2016 – Beat Diabetes
    • DME: CMS Face-to-Face Requirement
    • Surgical Services Policy and Procedure Manual
    • Anesthesia Policy and Procedure Manual
    • Post Anesthesia Care Unit Policy and Procedure Manual
    • Don’t Have the Time to Write Policies and Procedures?
    • HHS Office of Civil Rights Launches Phase 2 of HIPAA Audit Program
    • Do You Receive StayAlert! Notices in Your InBox?
    • Organ Transplant Interpretive Guidelines Update
    • Patient Safety Awareness Week March 13-19. Have You Taken the Pledge?
    • Patient Safety – What Exactly Is It?
    • Patient Safety Awareness Week March 13–19, 2016
    • Policy and Procedure Development
    • Eyewash Stations
    • Joint Commission Issues Sentinel Event Alert 56 – Detecting and Treating Suicide Ideation in All Settings
    • Comprehensive Long Term Care Policy and Procedure Manual
    • Long Term Care Environment of Care Manual
    • Home Health Policy and Procedure Manual
    • Reporting of Cases of the Zika Virus
    • Unintended Retention of a Foreign Object Once Again Tops Joint Commission List of Most Frequently Reported Sentinel Events
    • Pain Points
    • New USP Chapter: Hazardous Drugs – Handling in Healthcare Settings
    • Medical Device Reporting Requirements
    • Hospital Surveyor Worksheets
    • U.S. Senate Report Finds Fault with Hospitals Reporting Processes during Outbreak of Infections Linked to Medical Scopes
    • Medical Office Policy and Procedure Manual
    • HIPAA Guidelines Policy and Procedure Manual
    • Medical Records Health Information Management Manual
    • Advantages of MCN Healthcare’s Policy Management Software
    • Reporting Adverse Events Related to Medical Devices
    • Divergent Practices
    • HIPAA Regulations and a Patient’s Right to Access Health Information
    • CDC Issues Health Advisory about Recognizing, Managing, and Reporting Zika Virus Infections
    • Nurses Extraordinaire
    • Home Health Agency Disposal of PHI
    • HHS and USDA Release New Dietary Guidelines
    • The Third World
    • Nursing Staff Preparing CSPs
    • Schools for the Disabled and for the Blind
    • Home Health Policy and Procedure Manual
    • Ambulatory Surgical Center Policy and Procedure Manual
    • Cardiac and Pulmonary Rehabilitation Policy and Procedure Manual
    • Season’s Greetings from MCN Healthcare
    • Stark Law
    • Guide to Providing Effective Communication and Language Assistance Services
    • Critical Access Hospitals – CMS Definitions of Spouse and Marriage
    • Surgery and Pharmacy
    • Focused Dementia Care Survey Tools
    • FDA Issues Safety Communication for Intravascular Medical Devices
    • Comprehensive Compliance Plans for Healthcare Organizations
    • Administrative Manual for Critical Access Hospitals
    • Wound Management Policy and Procedure Manual
    • CMS Revising Discharge Planning Requirements
    • The Toby
    • Antibiotic Resistance
    • The People
    • CIHQ Requirements for Graduate Medical Education Programs
    • Joint Commission Warns that Temporary Names Put Newborns at Risk
    • Updated CMS Interpretive Guidelines for Pharmaceutical Services
    • Life as a Mission Team Member
    • Home Health Policy and Procedure Manual
    • Imaging Services Policy and Procedure Manual
    • Long Term Care Policy and Procedure Manual
    • ASC Infection Control Surveyor Worksheet
    • Increase in Fentanyl Drug Confiscations and Fentanyl-related Overdose Fatalities
    • Antibiotic Stewardship Program
    • CDC – Urgent Need for Improved Controlled Substance Prescribing Practices
    • Opening the Mind
    • Administrative Manual for Critical Access Hospitals
    • Home Health Policy and Procedure Manual
    • Ambulatory Surgical Services Policy and Procedure Manual
    • Administrative Manual for Ambulatory Care Facilities, version 10.0.2
    • Neonatal Intensive Care Unit Policy and Procedure Manual, version 3.0.2
    • Social Service and Discharge Planning Policy and Procedure Manual, version 4.0.2
    • LindenGrove Case Study
    • Poplar Bluff Regional Medical Center
    • Presbyterian/St. Luke’s Medical Center
  • Category: MCN Foundation
    • Adventures in Music and Culture with Peyton Shuffield: Enyan Denkyira, Ghana
    • We did it! MCN Foundation, FICCI-FLO and YOU!
    • Global Hand Washing Day October 15, 2018
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World – World Breastfeeding Week
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World – Elder Abuse On the Rise
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – Human Trafficking – A Form of Modern Slavery
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – Tuberculosis
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – Hepatitis
    • GIVINGTUESDAY ALL YEAR! Help to Empower Women and Improve Health Around the World! – World Cancer Day
    • GivingTuesday All YEAR! Help to Empower Women and Improve Health Around the World!
    • #GivingTuesday Is Here!
    • National Health Education Week
    • World Hepatitis Day – July 28, 2016
    • World Malaria Day – April 25, 2016
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 7
    • MCN Foundation’s Campaign – We are grateful.
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 6
    • MCN Foundation Fundraiser – For the love of a girl
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 5
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 4
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 3
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya – Day 2
    • MCN Foundation Travels to Ethiopia, Uganda and Kenya
    • MCN Foundation Works to Create Healthier Communities Around the World
  • Category: Policy Management
  • Category: Press Releases
    • MCN Healthcare Rebrands as MCN Solutions
    • Jessica Edwards Named Director of Customer Experience at MCN Healthcare
    • MCN Unveils StayAlert! Plus
    • Valeur Named To National Dance Company’s Board of Directors
    • MCN Healthcare Celebrates 30th Anniversary
    • MCN Healthcare Announces Expansion
    • MCN Healthcare Announces New Head of Sales and Marketing Efforts
  • Category: Uncategorized
    • Temporary Regulatory Changes from CMS – Verbal Orders
    • CMS Regulatory Changes in Response to COVID-19 Outbreak
    • FDA Updates
    • Joint Commission Urges Hospitals to Prepare for COVID-19 Surge
    • Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV)
    • Healthy People 2020
    • Raising Awareness for World Cancer Day
    • Go Red for Women: Ending Heart Disease and Stroke in Women
    • Advantages of Using EBSCO’s Dynamic Health with Policy Manager
    • Raising Awareness for National Blood Donor Month
    • The Benefits of Policy Manager
    • World Antibiotic Awareness Week 2019
    • The Benefits of Technology in Healthcare
    • We’re Celebrating Corporate Compliance and Ethics Week!
    • Cybersecurity and Your Healthcare Organization
    • Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling
    • OIG April 2019 Work Plan Updates – Home Health and ESRD
    • New Joint Commission New Quick Safety Issue Addresses Drug Diversion and Impaired Health Care Workers
    • CMS Updates Surveyor Guidance on Immediate Jeopardy
    • Class I Recall of CoaguChek XS PT Test Strips
    • Stryker Launches Voluntary Field Action for Specific Units of the LIFEPAK 15 Monitor/Defibrillator
    • CDC Provides First In-Season Estimates of Flu Illnesses
    • Joint Commission Issues Sentinel Event Alert on Developing a Reporting Culture
    • Holiday Decoration Safety Considerations
    • Class I Recall of Zimmer Biomet, Inc. Spinal Fusion and Long Bone Stimulators
    • Fresenius Kabi Recall of Sodium Chloride Injection, USP, 0.9%
    • CDC and APIC Announce Quick Observation Tools to Help Prevent Healthcare-associated Infections
    • FDA Safety Communication – Cybersecurity Updates Affecting Medtronic Implantable Cardiac Device Programmers
    • FDA Approves New Safety Measures for Immediate-release Opioid Analgesic Medications
    • CMS Proposes Elimination and Revision of Several Conditions of Participation
    • CMS Releases Final Interpretive Guidance for Home Health Agencies
    • Pfizer, Inc. Voluntary Nationwide Recall of One Lot of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle
    • Joint Commission Guidance on Use of Medical Scribes / Documentation Assistants
    • Emergency Management in Long Term Care – Best Practices for the Hazard Vulnerability Analysis
    • CDC Says No Current Multi-State Measles Outbreak
    • CDC Updates Recommendations for Timing of Pregnancy after Zika Exposure
    • AAP Warns of Counterfeit Neonatal Resuscitation Textbooks
    • Class I Recall of Arkon Anesthesia Delivery System
    • Westminster Pharmaceuticals, LLC. Nationwide Recall of Levothyroxine and Liothyronine
    • CDC Raises Awareness of Emerging Public Health Risks Associated with Tianeptine
    • Joint Commission Advice for Managing Medical Device-related Pressure Injuries
    • CMS Hospice Quick Reference Guide
    • CMS Proposed Physician Fee Schedule for CY 2019
    • TJC Standards Revisions for Fluoroscopy Services
    • CDC Health Alert Network (HAN) Health Update: Rising Numbers of Deaths Involving Fentanyl and Fentanyl Analogs, Including Carfentanil, and Increased Usage and Mixing with Non-opioids
    • CMS Requirement to Reduce Legionella Risk in Healthcare Facility Water Systems to Prevent Cases and Outbreaks of Legionnaires’ Disease
    • Draeger Medical Systems, Inc. Jaundice Meter JM-103 and Jaundice Meter JM-105 Recalled Due to Misinterpretation of Display Messages for Out of Range Values
    • TJC Quick Safety Issue – Identifying Human Trafficking Victims
    • Joint Commission Changes Survey Process for Assessing Safety Culture
    • TJC Announces Change in Citations for Ligature and Self-harm Deficiencies, Effective July 1, 2018
    • Scribes in the Hospital Setting
    • EMTALA and Disasters – Key Facts about Waivers
    • Class I Recall of Terumo Recalls Sarns TCM and TCM II Cooling and Heating Systems and HX2 Temperature Management Systems
    • Joint Commission Eliminates HHA Requirement Giving Patient Written Plan of Care
    • Getting Ahead of Sepsis
    • National Drug Take Back Day – April 28, 2018
    • FDA Alerts of Risk from 24-Hour Multi-Patient Use Endoscope Connectors
    • New Joint Commission Sentinel Event Alert – Physical and Verbal Violence Against Health Care Workers
    • Avoiding Medicare and Medicaid Fraud and Abuse – Roadmap for New Physicians
    • Radiological and Nuclear Emergency Preparedness Information
    • System 83 Plus Automated Endoscope Reprocessors (AERs) by Custom Ultrasonics: FDA Safety Communication – Completed Validation Testing
    • ISMP Alert – Hydromorphine Prefilled Syringe Attracted by MRI Magnet
    • CDC Highlights New Antibiotic-Resistant Germs
    • CDC Warns of Deadly Outbreak of Yellow Fever in Brazil
    • Joint Commission New Quick Safety Issue Addresses Preventing Newborn Falls and Drops
    • International Association for Healthcare Security & Safety’s New Guideline for Threat Management
    • Class I Recall of BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD)
    • Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
    • CMS Clarification on Fine Needle Aspiration Specimen Adequacy Assessment, Rapid On-site Evaluation (ROSE) and Workload Limits
    • Joint Commission Requirements for Pain Assessment and Management
    • Health Literacy Universal Precautions – Tools for Primary Care Practices
    • FDA Warns Duodenoscope Manufacturers about Failure to Comply with Required Postmarket Surveillance Studies
    • New Medicare Card Transition Beings in Less than a Month
    • Recall of Hydromorphone HCL Injection USP by Hospira
    • Unintended Retention of Foreign Objects Tops Joint Commission 2017 Sentinel Event List
    • FDA Issues Warning about Compounded Drug Products from Cantrell Drug Company
    • Joint Commission Releases Standards Revisions Related to Project REFRESH
    • Tips to Avoid Phishing Attacks
    • TJC Revisions to Fluoroscopy Imaging Standards, Effective July 1, 2018
    • CDC Offers Antibiotic Stewardship Course
    • Consequences for HIPAA Violations Don’t Stop When a Business Closes
    • SAMHSA Guidance on Medications for Opioid Use Disorder
    • CDC Informs of Multistate Salmonella Outbreak Linked to Kratom
    • Mammography Quality Standards Act Requires Direct Communication of Results to Patients
    • Attestation for Hospitals and the National Practitioner Data Bank
    • Joint Commission Announces Three Revisions to Life Safety Chapter
    • CDC Releases 2018 Children, Adolescents and Adults Immunization Schedules
    • FDA Drug Safety Communication Updates Status for Pentax Medical Duodenoscope Model ED-3490TK
    • TJC Issues Clarification on CMS Emergency Operations Plan Exercises
    • Risk of Death and Pulmonary Embolism with Extracorporeal Photopheresis (ECP) Treatment
    • Cyber Extortion
    • CMS Revises Skilled Nursing Facility Advanced Beneficiary Notice of Non-coverage Form
    • Drug Safety Communication for Ocaliva
    • FDA Clarifies Information About Payment and Reimbursement to Research Subjects
    • Class I Recall of AirLife Humidification Chamber Heated Breathing Circuit Kits by Vyaire Medical
    • Joint Commission Recommends Strategies for Eliminating Vincristine Administration Adverse Events
    • FDA Drug Safety Communication for Loperamide
    • DEA Final Rule for Opioid Use Disorder Drugs
    • Extension of Shelf Life Provided by Baxter Healthcare Corporation to Assist with IV Solution Shortages
    • Recall of Magno-Humphries Laboratories, Inc. Basic Drugs Brand of Senna Laxative Due to Mislabeling
    • Joint Commission New Maternal Infectious Disease Requirements
    • Joint Commission Patient Safety Systems Chapter
    • FDA Safety Communication for Zoll LifeVest 4000 Wearable Cardioverter Defibrillator
    • CMS Clarifies Accrediting Organization’s Role when a Provider or Supplier’s Deemed Status has been Temporarily Removed
    • Baxter Expands Voluntary Nationwide Recall to Include Second Lot of Nexterone Injection Due to Presence of Particulate Matter
    • Joint Commission Reminds of Updated Requirements for Deemed Status Home Health Agencies
    • FDA Warning Letter Regarding Lead Testing Issues
    • International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets
    • CDC 2017-2018 Influenza Vaccine Recommendations
    • Centurion Labs Issues Voluntary Nationwide Recall of Certain Lots of Ninjacof and Ninjacof A
    • EMTALA Requirements and the Medical Screening Exam
    • FDA Drug Information Update on Children’s Prescription Opioid Cough Medications
    • Joint Commission Standard Deletion Related to Performance on ORYX® Measures
    • Recent OIG Settlement Underscores Need for Strong EMTALA Policies
    • Recall of Sterile Drug Products by Bella Pharmaceuticals
    • Joint Commission Quick Safety Issue 35 – Minimizing Noise and Distractions in the OR and Procedural Units
    • Class I Recall of Zenith Alpha Thoracic Endovascular Graft by Cook Medical
    • Recall of Certain Lots of Amneal Pharmaceuticals Lorazepam Oral Concentrate
    • Hospice Quality Reporting Program (HQRP) Non-Compliance
    • Fungal Disease Awareness Week
    • Surgical Gowns Highlighted in “60 Minutes” Investigation Quarantined by CDC
    • Recall – Liquid Products Manufactured by PharmaTech and Distributed by Leader Brand, Major Pharmaceuticals, and Rugby Laboratories
    • FDA Warns of Potential Risks with Liquid-filled Intragastric Balloon Systems
    • FDA Issues Alert for Sterile Drug Products from Vital Rx, dba Atlantic Pharmacy and Compounding
    • CMS Clarifies Certain Fire and Smoke Door Annual Testing Requirements in Health Care Occupancies; Extends Compliance Date
    • CDC Health Advisory Notes Increase in Reported Cases of Cyclospora cayetanensis Infection
    • Rugby Laboratories Issues Voluntary Nationwide Recall of Diocto Liquid and Diocto Syrup Manufactured By PharmaTech, LLC Due to Possible Product Contamination
    • Vulnerabilities in Certain Siemens Molecular Imaging Products
    • Class I Recall of Datascope Corp. MAQUET Intra-Aortic Balloon Pumps
    • FDA Investigates Compounded Curcumin Emulsion Product for Injection by ImprimisRx
    • OSHA Now Accepting Electronic Submissions of Injury and Illness Reports
    • Timely Reporting of Provider Enrollment Information Changes
    • CMS Updates Medicare Payment Rates, Quality Reporting Requirements
    • Joint Commission Revises Standards that Address Medication Management Maintenance, Effective January 1, 2018
    • Recall of 0.9% Sodium Chloride Injection by ICU Medical
    • CMS Issues Clarification on Provision of Services for Community Mental Health Centers
    • FDA Drug Information Update on Guardian Pharmacy’s Compounded Triamicinolone and Moxifloxacin Product for Intravitreal Injection
    • Hepatitis B Vaccine Program
    • Recall of Cyclobenzaprine HCl and Amantadine HCl by Apace Packaging
    • New Medicare Card (formerly called SSNRI)
    • HHS Releases Improved Web Tools to Highlight Breaches of Health Information
    • Cantrell Drug Company Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to Lack of Sterility Assurance
    • Joint Commission Announces Survey Change for Office-Based Surgery Facilities in New York State
    • Oscor Recalls ATAR Reusable and Disposable Extension Cable(s) Due to Risk of Cable Separation from Connector
    • Class I Recall of Penumbra 3D Revascularization Device by Penumbra
    • FDA Safety Communication on Updated Status of FUJIFILM Medical Systems, U.S.A., Inc. Model ED-530XT Duodenoscopes
    • CMS Issues Proposed 2018 Physician Fee Schedule
    • HHS Issues Emergency Preparedness Resources for August Solar Eclipse
    • OIG Work Plan – July 2017 Updates
    • CMS Issues Revised Civil Money Penalty (CMP) Policies and CMP Analytic Tool
    • CMS Proposes 2018 Policy and Rate Changes for Hospital Outpatient, Ambulatory Surgical Center Payment Systems
    • CMS Memorandum Clarifies of Hepatitis C (HCV) Screening Exception for End Stage Renal Disease
    • Joint Commission’s New and Revised Pain Assessment and Management Requirements – Performance Improvement
    • CDC Offers New Vaccine Administration e-Learn Modules
    • CDC Health Advisory – Patients Receiving Eculizumab (Soliris®) at High Risk for Invasive Meningococcal Disease despite Vaccination
    • CMS Delays Effective Date for Home Health Conditions of Participation
    • Joint Commission Issues New and Revised Pain Assessment Requirements, Effective January 1, 2018
    • Recall of Atar Extension Cables by Oscor
    • Recall of Novopen Echo Insulin Delivery Device by Novo Nordisk
    • CMS Issues New Guidance for the Formatting of the Plans of Correction
    • Joint Commission Proposes New requirements for Maternal Status Documentation
    • CMS Issues Updated Hospital Discharge Appeal Notices
    • Time to Review Hurricane Readiness Policies
    • CDC Releases Influenza Vaccine Composition for 2017-2018
    • Petya Cyber Attack
    • PharMEDium Services Issues Voluntary Nationwide Recall of Specific Lots of Potassium Phosphate and Succinylcholine Chloride
    • The Joint Commission Proposes New Requirement Related to Measuring Pediatric Weights in Kilograms
    • Recall: Succinylcholine Chloride 20mg/mL 5mL Syringe by Fagron Sterile Services
    • Joint Commission Requirements for Providers Serving as Interpreters for Fellow Providers
    • Joint Commission Offers New Compendium of Resources for Venous Thromboembolism
    • Recall: Potassium Phosphate and Succinylcholine by Advanced Pharma
    • HHS Issues Cyber Notice
    • Recall: Venture Catheters by Vascular Solutions
    • Five Ways for Providers to Prepare for the New Medicare Cards
    • FDA Announces Availability of Draft Guidance on Electronic Records and Electronic Signatures in Clinical Investigations
    • CMS Requirements to Reduce Legionella Risk in Healthcare Facility Water Systems
    • Datascope System CS100, CS100i and CS300 Intra-Aortic Balloon Pumps Field Correction – Potential Electrical Test Failure Code
    • Teva Pharmaceuticals, USA Extends Voluntary Nationwide Recall to Consumer/User Level for One Lot of Paliperidone Extended-Release Tablets
    • Recall of Clindamycin Injection USP ADD-Vantage Vials by Alvogen
    • Recall of Sodium Bicarbonate Injection 8.4 Percent USP, Neut (Sodium Bicarbonate 4 Percent Additive Solution), Quelicin (Succinylcholine Chloride Injection USP), and Potassium Phosphates Injection by Hospira
    • Recall of Unexpired Nitroglycerin Injection in 5 Percent Dextrose USP by Advanced Pharma in Houston
    • FDA Safety Communication for Frameless Stereotaxic Navigation Systems
    • FDA Seeks Comment on Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids
    • National Time Out Day
    • Phillips Company Issues Voluntary Worldwide Recall of All Topical Products Due to Concerns of Manufacturing Practices
    • Recall of One Lot of Eliquis (apixaban) 5 mg Tablets
    • Recent Study Advises of Potential Neonatal Ethanol Exposure from Ethanol-based Hand Sanitizers in Isolettes
    • Quick Response Cyber Attack Checklist and Graphic
    • Data Submission Open for AHRQ Surveys on Patient Safety Culture Hospital Survey
    • FDA Releases List of Reusable Medical Devices Requiring Validated Instructions
    • Joint Commission adds New Requirement for Ambulatory Care Organizations Providing Sleep Center Services
    • Change in Institutional Review Board Oversight
    • Magellan Diagnostics Inc. Expands Recall for LeadCare Testing Systems Due to Inaccurate Test Results
    • CMS Issues Proposed Revision Requirements for Long-Term Care Facilities’ Arbitration Agreements
    • CMS Announces New Medicare Cards
    • TJC Clarification about Rated Fire Door Assembly Installed in Lesser Rated or Non-rated Barrier
    • Joint Commission Updates Sentinel Event Alert, Issue 47 – Radiation Risks of Diagnostic Imaging
    • TJC Clarifications about Emergency Department (ED) Occupancy Classification
    • Class I Recall of SpF PLUS-Mini and SpF XL IIB Implantable Spinal Fusion Stimulators by Zimmer Biomet
    • Recall of One Lot Number of Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles
    • Recall of Mibela 24 Fe Chewable Tablets by Lupin Pharmaceuticals Inc.
    • Class I Recall of Magellan Diagnostics Inc. LeadCare Plus and Ultra Testing Systems
    • Joint Commission Clarifies Requirements for Fire Drills
    • TJC Issues Clarifications to Life Safety Code Requirements
    • Class I Recall of Abbott-Thoratec HeartMate II LVAS Pocket System Controller
    • Joint Commission Revises National Patient Safety Goals Related to Healthcare-Associated Infections
    • FDA Safety Communication about Gadolinium-based Contrast Agents
    • Class I Recall of V60 Non-invasive Ventilator by Respironics
    • CMS Requirements for Notice of Transfer or Discharge in Long Term Care
    • CDC Issues Health Advisory about Potential for Falsely Low Blood Lead Test Results from LeadCare® Analyzers
    • HHS Updates on International Cyber Threat to Healthcare Organizations
    • FDA Safety Communication – Magellan Diagnostics’ LeadCare Testing Systems Use with Venous Blood
    • Joint Commission Deletes Numerous EPs from Nonhospital Accreditation Programs
    • Class I Recall of ReFlow’s Wingman 35 Crossing Catheters due to Tip Separation
    • Recall of Coronary Catheters by Abbott – Difficulty in Removing Balloon Sheath
    • FDA Drug Safety Communication for Canagliflozin (Invokana, Invokamet)
    • Update on International Cyber Threat to Healthcare Organizations
    • CDC Updates Surgical Site Infection Guidelines
    • New Joint Commission Field Reviews
    • Joint Commission Highlights Importance of Crash Cart Preparedness
    • FDA Drug Safety Communication – Updated Warnings for Oral and Injectable Fluoroquinolone Antibiotics
    • CMS Releases Lookup Tool to Help Clinicians Determine MIPS Participation Status
    • Spotlight on Emergency Preparedness the Long Term Care Environment
    • Class I Recall of Ventricular Assist Device Controllers and DC Adapter by Medtronic Mechanical Circulatory Support (formerly HeartWare Inc.)
    • Recall of Wingman35 Crossing Catheters by ReFlow Medical – Tip Splitting or Separation
    • Medtronic Letter to Healthcare Providers Regarding NavLock Tracker
    • World Hand Hygiene Day, May 5, 2017
    • Class I Recall of Medtronic HVAD(TM) System Controllers and DC Adapters
    • Best Practices for Use of Fingerstick Devices
    • FDA Drug Safety Communication about General Anesthetic and Sedation Drugs for Children
    • Joint Commission Announces Completion of Phase III EP Review Project
    • CMS Releases Electronic Staffing Submission – Payroll-Based Journal Update
    • FDA Warns of Fraudulent Cancer Treatments
    • Advancement of Medical Instrumentation (AAMI) Report – Risk Management of Radio-frequency Wireless Coexistence for Medical Devices and Systems
    • Recall of Hospira 25% Dextrose Injection, USP (Infant)
    • CDC Releases General Best Practice Guidelines for Immunization
    • FDA Issues Drug Safety Communication – Restricting Use of Codeine and Tramadol Medicines in Children, Recommending Against Use in Breastfeeding Women
    • CMS Proposes Regulation Changes for Accrediting Organizations (AOs) Transparency and Termination Notices
    • Joint Commission Proposes Requirements for the New Thrombectomy-capable Stroke Center Certification Program
    • CDC Interim Guidance for Managing Occupational Exposure to Zika Virus for Healthcare Personnel
    • OIG Releases Resource Guide for Measuring Compliance Program Effectiveness
    • Joint Commission Clarifies Requirements for Monitoring and Maintenance of Refrigerators in Patient Rooms
    • CMS Releases Administrative Simplification Factsheet
    • DNV GL Advisory Notice – NIAHO Accreditation Requirements, Interpretive Guidelines and Surveyor Guidance for Critical Access Hospitals
    • Recall of StrataMR Adjustable Valves and Shunts by Medtronic
    • Recall of Sterile Compounded Products by Isomeric Pharmacy Solutions
    • TJC Requirements for Updating H&P during Inpatient Stay
    • Medtronic Announces Worldwide Voluntary Field Corrective Action for Newport™ HT70 and Newport™ HT70 Plus Ventilators
    • Medication Titration Orders
    • CMS Releases Information to Assist Providers and Suppliers in Meeting the New Training and Testing Requirements of the Emergency Preparedness Requirements
    • FDA Announces Recall of EpiPen and and EpiPen Jr Auto-Injector
    • CMS Conditions of Participation for Home Health Agencies – Proposed Delay of Effective Date
    • Class I Recall of the Prelude Short Sheath Introducer by Merit Medical Systems
    • CMS Home Health Conditions of Participation – Comprehensive Assessment
    • FDA Updates Heater-Cooler Device Information
    • CMS Home Health Conditions of Participation Related to the Provision of Written Information to the Patient
    • CDC Updates Specimen Collection, Shipping, and Testing Guidance for Suspected Acute Flaccid Myelitis (AFM) Cases
    • Class I Recall of Phillips Healthcare’s HeartStart MRx Monitor Defibrillator
    • CMS Home Health Conditions of Participation Related to Coordination of Care
    • CMS Home Health Conditions of Participation – Care Planning
    • Joint Commission Proposes Revisions to National Patient Safety Goal Requirements Related to Suicide
    • FDA Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
    • CDC Warns of Potential Increased Risk to Blood and Tissue Safety for Certain FL Counties
    • FDA Investigating Increased Rate of Major Adverse Cardiac Events with Absorb GT1 Bioresorbable Vascular Scaffold (BVS) by Abbott Vascular
    • New Tools for Patient-Based Safety Interventions in Primary Care
    • FDA Drug Safety Communication for Viberzi (eluxadoline)
    • Policies that Address Delays in Treatment
    • Best Practices to Prevent Patient Falls in Hospitals
    • Class I Recall of SynchroMed II and SynchroMed EL Implantable Drug Infusion Pumps by Medtronic
    • CMS Releases FAQs for Medicare Outpatient Observation Notice (MOON)
    • FDA Safety Communication for SPS-1 Static Preservation Solution Distributed by Organ Recovery Systems
    • CMS Home Health Conditions of Participation – Patient Rights (Effective July 13, 2017)
    • FDA Safety Communication – Balloon Angioplasty Devices to Treat Autonomic Dysfunction
    • Revisions to Joint Commission’s Life Safety Chapter, Effective July 1, 2017
    • CDC Study Estimates 20-fold Increase in Birth Defects Related to Zika
    • HHS OIG Issues Fraud Alert – Telephone Number Used in Scam
    • New CMS MLN Matters Article Addressing Advance Care Planning Implementation for OPPS
    • Joint Commission Issues Sentinel Event Alert 57 – The Essential Role of Leadership in Developing a Safety Culture
    • TJC Requirements for Testing and Maintaining Non-high-risk Utility Systems
    • Avella Specialty Pharmacy Announces Recall of Injectable Products
    • Radiological Health Reporting Forms
    • TJC Revisions to Program Requirements Based on NFPA 2012 Life Safety Code Effective July 1, 2017
    • Multi-state Outbreak of Seoul Virus – Update
    • 2016-2017 Flu Vaccine Reducing Risk by Nearly Half
    • Using Antibiogram’s in Nursing Homes
    • Class I Recall of Comprehensive Reverse Shoulder by Zimmer Biomet
    • Educating Nursing Home Staff about Antibiotic Stewardship
    • Synergy Rx Pharmacy Recalling Human Chorionic Gonadotropin
    • CDC Releases 2017 Immunization Schedules
    • USP to Seek Second Round of Public Comments for General Chapter 797 Pharmaceutical Compounding—Sterile Preparations
    • Class I Recall of Physio-Control Recalls LIFEPAK15 Monitor and Defibrillator
    • Joint Commission Issues Addendum to Sentinel Event, Issue 45 – Preventing Violence in the Health Care Setting
    • FDA Alert – Potential Risks with Fluid-filled Intragastric Balloons
    • Recall of Ibuprofen Lysine Injection by Exela Pharma Sciences
    • Class I Recall of CareFusion’s Alaris Syringe Pump
    • New Communication Tool for Radiation Emergencies
    • OSHA Reminds Employers to Post Injury and Illness Summaries Now through April
    • FDA MedWatch – Chlorhexidine Gluconate: Rare but Serious Allergic Reactions Reported
    • Joint Commission Clarifies “Observers” Standard
    • DMEPOS Competitive Bidding Round 2019 Announced
    • Class I Recall of Halo One Thin-Walled Guiding Sheath by Bard Peripheral Vascular Inc.
    • Class I Recall of bioMerieux NucliSENS easyMAG Magnetic Silica and NucliSENS Magnetic Extraction Reagents
    • CDC Health Advisory – Investigation of Seoul Virus Outbreak Associated with Home-based, Rat-breeding Facilities in Wisconsin and Illinois
    • AHRQ Toolkit to Improve Safety for Mechanically Ventilated Patients
    • CMS Releases Instructions for Using MOON
    • Hospira Issues Recall of One Lot of Vancomycin Hydrochloride for Injection, USP
    • TJC Recommendations for Protecting Patients during Utility System Outages
    • Joint Commission Proposed Requirements Related to Pain Assessment and Management
    • REMINDER – FDA Ban on Powdered Medical Gloves is Now Effective
    • Educating Patients on Antimicrobial Medications
    • Revisions to the Federal Policy for the Protection of Human Subjects (the Common Rule)
    • FDA Safety Communication Update – ED-3490TK Video Duodenoscope by Pentax
    • FDA Safety Communication for Zoll LifeVest 4000 Wearable Cardioverter Defibrillator
    • Outpatient Visits for Influenza-like-Illness are above the National Baseline: Minimize False Rapid Influenza Diagnostic Tests
    • Voluntary Field Action for LIFEPAK 1000 Defibrillators by Physio-Control
    • Fujifilm Plans on Removing Legacy 250/450 Duodenoscope Models from Clinical Use
    • CMS Finalizes Revised Home Health Conditions of Participation
    • Recall of Medrad Intego PET Infusion System Source Administration Sets by Bayer
    • FDA Safety Concerns with Implantable Infusion Pumps in the Magnetic Resonance Environment
    • FDA Warns of Potential Problems with Battery-Powered Mobile Medical Carts
    • Joint Commission Revisions to Behavioral Health Care Standards, Effective January 1, 2018
    • Cybersecurity Vulnerabilities Identified in St. Jude Medical’s Implantable Cardiac Devices and Merlin@home Transmitter
    • Class I Recall of Nurse Assist Inc. Normal Saline Flush IV Syringes Due to Possible Burkholderia Cepacia Bloodstream Infections
    • CMS Rescinds Policy Disallowing Hospital Security Units
    • Joint Commission National Patient Safety Goal Focuses on CAUTI Prevention
    • CMS Issues Clarification of Automatic Fire Sprinkler System Installation Requirements in Attic Spaces in Long-Term Care Facilities
    • TJC Issues Clarification on Text Messaging of Patient Care Orders
    • FDA Issues Safety Communication for ZIKV Detect IgM Capture ELISA by InBios International, Inc.
    • CDC Resources for Clinicians Using New Opioid Prescribing Guidelines
    • Class I Recall of Standard Offset Cup Impactor with POM-C Handle by Greatbatch Medical
    • Clozapine REMS Delayed
    • FDA Bans Powdered Gloves (Surgeon Gloves and Exam Gloves)
    • Long-Term Care Regulation – Enforcement of Rule Prohibiting Use of Pre-dispute Binding Arbitration Agreements is Suspended
    • CDC Designates the City of Brownsville, Texas as a Zika Cautionary (yellow) Area for Testing and Travel Guidance
    • FDA Issues New Warnings for Use of General Anesthetic and Sedation Drugs in Young Children and Pregnant Women
    • Joint Commission Releases Prepublication Standards for Phase 1 Revisions to Behavioral Health Care Manual
    • Pioglitazone-containing Medicines – Updated FDA Review
    • CMS Releases Updated Medicare Outpatient Observation Notice
    • Class I Recall of Convenience Kits Containing Multi-Med Single Lumen Catheters by Centurion
    • National Influenza Vaccination Week: What Does Medicare Cover?
    • CDC Announces Updated VIS for Gardasil-9 is Available
    • Decorating for the Holidays? Keep Safety in Mind
    • CMS Posts FAQs about New Emergency Preparedness Rule
    • Class I Recall of Medtronic Recalls Neurovascular Products
    • OCR Issues Alert about Phishing Email Targeting HIPAA Covered Entities
    • It’s Time to Review Your Compliance Plan!
    • Happy Thanksgiving!
    • Class I Recall of FindrWIRZ Guidewire System by SentreHeart
    • Tri-Coast Pharmacy Inc. Voluntarily Recalling All Sterile Products Prepared Between May 17, 2016 and November 17, 2016
    • Office of Inspector General Releases FY 2017 Work Plan for Home Health
    • Recall of Sterile Drug Products by Cantrell Drug Company
    • Office of Inspector General Releases FY 2017 Work Plan for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies
    • Office of Inspector General Releases FY 2017 Work Plan for Nursing Homes and Hospice
    • Joint Commission Releases 2017 National Patient Safety Goals
    • Department of Homeland Security Issues Updated Terrorism Advisory System Bulletin
    • FDA Announces Label Changes for Essure Permanent Birth Control System by Bayer Healthcare
    • Office of Inspector General Releases FY 2017 Work Plan for Hospitals
    • Office of Inspector General FY 2017 Work Plan
    • FDA Draft Guidance on Certain Ultrasonic Surgical Aspirator Devices
    • New Guide Helps Nursing Homes Tackle Antimicrobial Stewardship
    • Transplant Centers: CMS Requirements – Clinical Experience
    • The Accreditation Council for Graduate Medical Education Seeks Input on Proposed Revisions to Common Program Requirements
    • CDC – First Cases of Candida auris Reported in the United States
    • CMS Issues Final Rule for 2017 Physician Payment Schedule
    • CMS Proposed Rule – Fire Protection Guidelines for Applicable Dialysis Facilities
    • CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
    • Strategies for Transitioning to New Tubing Connectors
    • HHS’ National Action Plan to Prevent Health Care-Associated Infections – New Targets and Metrics
    • Social Security Number Removal Initiative (SSNRI)
    • CMS Extends Timeline for Hospice “Extraordinary Circumstances” Exemption
    • FDA Announces Class-wide Labeling Changes for All Prescription Testosterone Products
    • Class I Recall of St. Jude Medical Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy Defibrillators (CRT-D)
    • Class I Recall of HeartWare Ventricular Assist Device Pumps by HeartWare Inc.
    • New FDA Website for Reporting Allegations of Regulatory Misconduct
    • New National Health Care-Associated Reduction Targets and Metrics
    • Class I Recall of Willy Rusch Tracheostomy Tube Set by TeleFlex Medical
    • Radiation Therapy Devices by Multidata Systems International: Discontinue Use – Concerns about Risks to Patients
    • CDC Health Advisory Updates Guidance – Zika Virus and Miami-Dade County, Florida
    • New HIPAA Settlement Underscores Importance of Managing Security Risks
    • Medtronic Announces Voluntary Recall of its Pipeline Embolization Device, Alligator Retrieval Device, X-Celerator Hydrophilic Guidewire, Ultraflow and Marathon Flow Directed Micro Catheters
    • ACHC Requirements for Informing Patients of the Grievance Process
    • Class I Recall of Skintact DF29N Multi-function Defibrillation Electrodes by Leonhard Lang
    • FDA Updated Safety Communication – Stӧckert 3T Heater-Cooler System by LivaNova PLC (formerly Sorin Group Deutschland GmbH)
    • CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
    • Medicare Quarterly Provider Compliance Newsletter
    • New HHS Rule Provides Public with More Information about Clinical Trials
    • FDA Safety Communication – Premature Battery Depletion of St. Jude Medical ICD and CRT-D Devices
    • FDA Issues Final Rule Amending List of Drug Products That May Not Be Compounded
    • HHS Office for Civil Rights Issues Guidance on HIPPA and Cloud Computing
    • Joint Commission Changes Two Laboratory Standards
    • CMS Issues Final Rule Reforming Requirements for Long-Term Care Facilities
    • Nurse Assist Initiates Nationwide Voluntary Recall of All Unexpired Lots of I.V. Flush Syringes
    • Class I Recall of Vascular Solutions, Inc. Twin-Pass® Dual Access Catheters
    • Joint Commission Seeks Comments on Proposed revisions to National Patient Safety Goals on Health Care-Associated Infections
    • HHS Office for Civil Rights Offers Insight into Availability of PHI Maintained by a Business Associate
    • Voluntary Recall of all Unexpired Lots of Baxter International’s 50mm 0.2 Micron Filters
    • CDC Updates Interim Guidance for Pre-Conception Counseling and Prevention of Sexual Transmission of Zika
    • Institute for Safe Medication Practices Issues Alert about Possible Fluid Leakage with Parenteral Syringes
    • Antibiotic “Time outs”
    • Class I Recall of Small Battery Drive and Small Battery Drive II Adaptor and Light Adaptor by DePuy Synthes – Possible Explosion Risk
    • Joint Commission Deletes 51 Elements of Performance in Hospital Accreditation Standards
    • Affordable Care Act of 2010 – Section 1557 – Grievance Procedure Requirements for Discrimination
    • DEA Issues Warning About Carfentanil
    • HHS Issues Final Rule on ClinicalTrials.gov Requirements
    • Recall of Sterile Products by Wells Pharmacy Network – Concern for Lack of Sterility Assurance
    • HHS Releases Additional Affordable Care Act Section 1557 Resources
    • Affordable Care Act of 2010 – Section 1557 – Notices of Nondiscrimination
    • CMS Emergency Preparedness Requirements for Hospitals – Part II
    • CDC Updates Guidance for Wynwood (FL) Neighborhood with Active Zika Transmission
    • Updated Requirements for Notifying The Joint Commission about Organizational Changes
    • Recall of Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals
    • CMS Emergency Preparedness Requirements for Hospitals – Part I
    • CMS Final Rule Addresses Emergency Preparedness
    • CMS Interpretive Guidance about Protecting Resident Privacy and Prohibiting Mental Abuse Related to Photographs, Audio and or Video Recordings by Nursing Home Staff
    • Recall of Six Batches of Novo Nordisk Inc., GlucaGen HypoKit (glucagon [rDNA origin] for injection)
    • CMS Releases Additional Resources to Assist with Advance Care Planning
    • Recall of Family Eye Care Wash by united Exchange Corp.
    • Best Practices for Reducing Risk of Infections Associated with Medical Equipment, Devices and Supplies
    • Class I Recall of Cook Medical Recalls Roadrunner UniGlide Hydrophilic Wire Guide Because of Potential Coating Contamination
    • CDC Provides Example Labels for 2016-2017 Influenza Vaccine
    • FDA Drug Safety Communication: Opioid Pain or Cough Medicines Combined With Benzodiazepines – Serious Risks and Death
    • Impax Laboratories, Inc. Issues Voluntary Nationwide Recall for One Lot of Lamotrigine Orally Disintegrating Tablet 200 mg
    • CDC Health Alert – Influx of Fentanyl-laced Counterfeit Pills and Toxic Fentanyl-related Compounds Further Increases Risk of Fentanyl-related Overdose and Fatalities
    • FDA Advises Testing for Zika Virus in all Donated Blood and Blood Components in the US
    • Class I Recall of Alere’s INRatio and INRatio2 PT INR Monitoring System Due to Incorrect Test Results
    • FDA Safety Communication: Programmable Syringe Pumps – Problems with Fluid Flow Continuity at Low Infusion Rates
    • Are You Required to Comply with Electronic Standards?
    • Safety Information about Heater-Cooler Devices used During Cardiothoracic Surgery
    • CDC Health Alert Network Health Advisory Expands Guidance for Zika Virus – Miami-Dade, Florida
    • Recall of Eyesaline Eyewash by Honeywell
    • CMS Finalizes Hospital Inpatient Prospective Payment System (IPPS) and Long Term Acute Care Hospital (LTCH) Final Rule Policy and Payment Changes for Fiscal Year (FY) 2017
    • FDA Safety Communication – System 83 Plus Automated Endoscope Reprocessors by Custom Ultrasonics
    • Recall of Roadrunner UniGlide Hydrophilic Wire Guides by Cook Medical
    • FDA Issues Import Alert for All Drugs Produced by Laxachem Organics in India
    • Class I Recall of BioMerieux NucliSENS® easyMAG® Magnetic Silica (MagSil)
    • Best Practices for Preventing Wrong Site, Wrong Procedure and Wrong Person Surgery
    • HHS, HUD and DOJ Issue Letter to State and Local Agencies Regarding Life and Safety Benefits for Immigrants
    • Patient Falls Top TJC’s 2Q 2016 List of Reported Sentinel Events
    • Best Practices for Preventing Unintended Retention of a Foreign Object
    • PharmaTech Issues Voluntary Nationwide Recall of Liquid Drug and Dietary Supplements – Risk of Product Contamination
    • Joint Commission releases Sentinel Event Statistics through 2Q 2016
    • CDC Releases Updated Vaccine Information Statements
    • Recall of 0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira
    • Class I Recall of VentStar Oxylog 3000 Pediatric Patient Breathing Circuit by Dräger
    • FDA Issues Draft Guidance – Insanitary Conditions at Compounding Facilities
    • Recall of Amikacin Sulfate Injection USP
    • Recall of Comfort Shield Barrier Cream Cloths by Sage Products – Product Contamination
    • CDC Issues Health Advisory with Travel Guidance Related to Miami Neighborhood with Active Zika Spread
    • CDC Updates Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure
    • AABB and American Red Cross Warn of Critical Blood Supply Shortage
    • FDA Issues Advice to Blood Collection Establishments on Non-Travel Related Cases of Zika Virus in Florida
    • Class I Recall of AVEA Ventilator by CareFusion – Electrical Issue May Cause Unexpected Shutdown
    • FDA Releases Influenza Virus Vaccine for the 2016-2017 Season
    • U.S. Department of Health and Human Services Office for Civil Rights (OCR) Settles HIPAA Violations with University of Mississippi Medical Center
    • Talon Compounding Pharmacy Issues Voluntary Nationwide Recall of HCG and Sermorelin Due to Lack of Sterility Assurance
    • FDA Drug Safety Communication about Fluoroquinolone Antibacterial Drugs for Systemic Use – Warnings Updated Due to Disabling Side Effects
    • Joint Commission’s NEW Standard MM.09.01.01 – Antimicrobial Stewardship
    • Schools to Hold Programming Courses In 2016
    • The Future Of Online And Mobile Banking
    • New Limited Edition Line Of Quality Headphones
    • Changing The Way We Look At Telecomunication
    • New Workout App Promises Great Results
    • News From The 2016 Technology Expo
    • Top 25 Productivity Apps Of 2016
    • Twitter Making Major Changes To Its UI
    • New Music Streaming App Release In May
    • Machine Vision’s Achilles’ Heel Revealed by Google Brain Researchers
    • The AI That Cut Google’s Energy Bill Could Soon Help You
    • Nvidia’s Eye-Tracking Tech Could Revolutionize Virtual Reality
    • Class I Recall: Angiodynamics Soft Vu Omni Flush Angiographic Catheter by Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions)
    • CDC Assisting Utah Investigation of Zika Virus Infection Apparently not Linked to Travel
    • HHS Announces New Actions to Combat Opioid Epidemic
    • Recall of Oral Liquid Docusate Sodium by PharmaTech: Contamination with B. Cepacia
    • CMS Proposes FY2017 Physician Fee Schedule
    • OCR Releases Fact Sheet on Ransomware and HIPAA
    • Recall of INRatio and INRatio2 PT/INR Monitor System by Alere: Potentially Inaccurate INR Results
    • FDA Approves a Dedicated Syringe to be used with Humulin R U-500 Insulin
    • Update: Multistate Outbreak of Burkholderia cepacia Infections
    • CMS Issues Proposed Rule for Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System
    • ACHC Requirements for Transferring a Patient Receiving Home Health Services
    • CMS Finalizes Rule Giving Providers and Employers Improved Access to Information for Better Patient Care
    • CMS Makes Correction to New Fire Safety Rule
    • Joint Commission Publishes Prepublication Requirements for New Antimicrobial Stewardship Standard MM.09.01.01
    • CDC Issues Clinical Alert to U.S. Healthcare Facilities – Candida auris
    • Joint Commission Quick Safety Issue 24 – Bullying Has No Place in Healthcare
    • Hurricane Readiness for Healthcare Providers
    • CMS Memorandum – CMS will begin Surveying for Compliance with the 2012 LSC and HCFC on November 1, 2016.
    • CDC Issues Health Update with Recommendations for Subsequent Zika IgM Antibody Testing
    • CDC Issues Health Advisory about Best Practices for Using PCR to Diagnose Haemophilus influenzae and Neisseria meningitidis and Identify Serotype or Serogroup
    • ACHC Requirements for Home Health Aide Duties
    • HIPAA Considerations and Emergency Response during Acts of Mass Violence
    • CMS Proposed Rule Prohibits Discrimination, Reduces Hospital-Acquired Conditions, and Promotes Antibiotic Stewardship in Hospitals
    • CDC Issues Health Alert about First mcr-1 Gene in E. coli Bacteria found in a Human in the United States
    • FDA Drug Safety Communication: Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR) – Strengthened Kidney Warnings
    • FDA issues Final Guidance Documents on Bulk Substances Used during Compounding
    • UPDATED Drug Safety Communication for Zecuity (sumatriptan) Migraine Patch
    • FDA Seeks Comments on Draft Guidance about Dissemination of Patient-Specific Information from Devices by Device Manufacturers
    • OCR Releases Tools to Help Individuals Understand Access to Health Information Rights under HIPAA
    • FDA Issues Drug Safety Communication for Loperamide (Imodium)
    • ACHC Requirements for Conformance with Physician Orders
    • FDA Releases Final Individual Patient Expanded Access Investigational New Drug Application Form 3926
    • FDA Issues Drug Safety Communication for Zecuity
    • ACHC Drug Regimen Review Standard – One of Most Cited Deficiencies
    • Safety Communication about the Stӧckert 3T Heater-Cooler System by Sorin Group Deustchland GmbH
    • Joint Commission Seeks Input on Proposed and New Laboratory Changes
    • Colistin-resistant mcr-1 E. coli Discovered in U.S.
    • Class I Recall of Medtronic Respiratory and Monitoring Solutions Battery Pack Used on Patient Monitors Due to Potential Fire Risk
    • CDC Issues Health Advisory Regarding Diagnostic Testing of Urine Specimens for Suspected Zika Virus Infection
    • Class I Recall of Hummi Micro-Draw Blood Transfer Device by Hummingbird Med Devices
    • CMS Survey and Certification Group 2016-2017 Nursing Home Action Plan
    • AHRQ Communication and Optimal Resolution (CANDOR) Toolkit
    • Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria Seek Input on Strategies to Combat Antibiotic-Resistance
    • CDC Monitoring Possible Zika Virus Infection among Pregnant Women in the U.S. and Territories
    • FDA Issues Drug Safety Communication for Ketoconazole Oral Tablets
    • Recall of Well Care Compounding Pharmacy Sterile Compounded Products
    • FDA Issues Drug Safety Communication for Canagliflozin (Invokana, Invokamet)
    • Nondiscrimination in Health Programs and Activities Final Rule Brings New Requirements for Accommodating Persons with Limited English Proficiency
    • FDA Seeks Comments on Draft Guidance, Use of Electronic Health Record Data in Clinical Investigations
    • HHS Issues Final Rule to Advance Health Equity and Reduce Health Care Disparities
    • FDA Issues Drug Safety Communication for Fluoroquinolone Antibacterial Drugs
    • Joint Commission Follows Suit with CMS and Adopts 2012 NFPA 101 Life Safety Code
    • CMS Clarifies Guidance on Federal Requirements for Providing Services to Justice Involved Individuals
    • FDA Issues Drug Safety Communication for Olanzapine – Rare but Serious Skin Reactions
    • New CDC Campaign Reminds Healthcare Providers that “Clean Hands Count”
    • Recall of PharMEDium Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl)
    • CMS Final Rule on Fire Safety Requirements for Certain Health Care Facilities
    • Class I Recall of Dialog+ Hemodialysis Systems by B. Braun Medical
    • Recall of Beacon Tip Technology Catheters by Cook Medical
    • Joint Commission Revises Position on Texting Orders
    • FDA Announces a Brand Name Change for Brintellix (vortioxetine)
    • May is Viral Hepatitis Month
    • CMS Proposes Replacing Meaningful Use Program
    • The CMS Updates State Operations Manual Appendix A, Pharmaceutical Services Conditions of Participation
    • FDA Drug Safety Communication on Oral Diflucan (fluconazole) During Pregnancy
    • Recall of Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi
    • Joint Commission Deletes Requirements for Hospitals
    • Multistate Outbreak of Elizabethkingia anophelis – What You Need to Know
    • Best Practices for Compliance with Joint Commission’s Ambulatory Care Hazard Vulnerability Analysis Requirement
    • FDA Proposes Ban on Electrical Stimulation Devices Intended to Treat Self-injurious or Aggressive Behavior
    • DHS Warns Hospitals about Ransomware Risks
    • Medtronic Recalls Covidien Oridion Labeled Capnostream 20 and Capnostream 20p Patient Monitor Battery Packs
    • FDA Issues Draft Guidance Documents Related to Human Drug Compounding
    • CMS Issues Proposed Hospital Inpatient Prospective Payment System (IPPS) for Fiscal Year (FY) 2017
    • Class I Recall of the Boston Scientific Corporation Fetch 2 Aspiration Catheter
    • FDA Alerts Healthcare Professionals Not to Use Sterile Drug Products from Pharmakon Pharmaceuticals, Inc.
    • CMS Medicare Quarterly Provider Compliance Newsletter – Screening Colonoscopy and Physician Documentation
    • Recall of 50% Magnesium Sulfate Injection, USP by Hospira
    • CDC Study Confirms Zika Virus Causes Microcephaly and Other Serious Birth Defects
    • OIG Releases 2016 Compendium of Unimplemented Recommendations
    • Class I Recall of Focus Diagnostics Simplexa Herpes Simplex Virus 1 & 2 and Simplexa Group A Step Direct Kits
    • Class I Recall of G4 Platinum and G5 Mobile Continuous Glucose Monitoring System Receivers by Dexcom – Audible Alarm Failure
    • Recall of Boston Scientific‘s Fetch 2 Aspiration Catheter
    • Recall of Guardian II Hemostasis Valves by Vascular Solutions, Inc.
    • CIHQ Requirements for Interpretive and Translation Services
    • FDA Drug Information Update for Metformin-containing Medications
    • HHS Releases a National Pain Strategy
    • Joint Commission’s New Requirements for Diagnostic Imaging Services
    • CMS Memorandum: Personnel Policies for Individuals Directing or Performing Non-waived Tests
    • FDA Safety Communication: Diabetes Medications Containing Saxagliptin and Alogliptin – Risk of Heart Failure
    • Interference between Computed Tomography (CT) and Electronic Medical Devices – Current Understanding of Potential Risk
    • FDA Warns of Potential for Counterfeit Raw Material with Urogynecologic Surgical Mesh Implants by Boston Scientific
    • FDA Warns of a Lack of Sterility with Sterile Drug Products by Medaus Pharmacy
    • ACHC Top-Cited Survey Deficiency
    • CMS FAQs about Advance Care Planning as an Optional Element of an Annual Wellness Visit (AWV)
    • CIHQ Requirements for Storage of Medications
    • Class I Recall of Cook Medical’s Central Venous Catheter and Pressure Monitoring Sets and Trays
    • FDA Safety Communication – Do Not Use the OxySure Portable Emergency Oxygen System, Model 615 by OxySure Therapeutics, Inc
    • FDA Offers Five New Unique Device Identification (UDI) Education Modules
    • Recall of B. Braun Medical Inc., 5% Dextrose Injection
    • US Zika Pregnancy Registry
    • Recall of Compounded Products by Reliable Drug Pharmacy
    • TJC Revises PC.01.03.01, EP 6 for Psychiatric Hospitals, Effective April 4, 2016
    • New and Revised Joint Commission National Patient Safety Goal Focusing on Catheter-associated Urinary Tract Infections (CAUTIs)
    • New Drug Safety Communication: FDA Warns about Several Safety Issues with Opioid Pain Medicines and Requires Label Changes
    • HHS Office of Civil Rights Launches Phase 2 of HIPAA Audit Program
    • Recall of Sodium Bicarbonate Injection, USP by Hospira
    • CDC Issues Guideline for Prescribing Opioids for Chronic Pain
    • Patient Safety Hot Topic – Cybersecurity and Medical Devices
    • Class I Recall of Arrow International Inc.’s Intra-Aortic Balloon Catheter Kits and Percutaneous Insertion Kits
    • Class I Recall of GlideScope Titanium Single-Use Video Laryngoscope by Verathon
    • Patient Safety Hot Topic – Discharge Practices
    • Patient Safety Hot Topic – Clostridium difficile
    • Patient Safety Hot Topic – Patient Falls
    • FDA Issues Drug Information Update Clinical Trials with Zydelig (idelalisib) in Combination with other Cancer Medicines
    • Patient Safety Hot Topic – Adverse Drug Events
    • Teleflex Incorporated Announces Worldwide Recall of ARROW International Intra-Aortic Balloon Catheter Kits and Percutaneous Insertion Kits
    • FDA Alerts Health Professionals Not to Use Human and Animal Sterile Drug Products Produced and Distributed by I.V. Specialty, Ltd., Austin, Texas
    • Recall of Teva Pharmaceutical’s Amikacin Sulfate Injection USP, 1 gram per 4mL (250 mg per mL) Vials
    • FDA Letter to Health Care Professionals with Warning about Magnetic Interference between Breast Tissue Expanders with Magnetic Ports and Implantable Cardioverter-defibrillators or Pacemakers
    • OSHA Seeks Comments on Guidance for Determining Potential Health Hazards of Chemicals
    • CMS Releases ICD-10 Assessment Toolkit
    • Recall of Sagent Pharmaceuticals, Inc Fluconazole Injection, USP
    • CDC Vital Signs Report Shows Some Progress but Additional Action Needed to Prevent Health Care Acquired Infections
    • Dräger Evita V500 and Babylog VN500 Ventilators – Recall Expanded to Include Optional PS500 Batteries with New Power Supply Firmware
    • Joint Commission Seeks Comments on Proposed New integrated Care Certification (ICC) Post-Acute Expansion
    • New HIPAA Guidance Reiterates Patients’ Right to Access Health Information and Clarifies Appropriate Fees for Copies
    • CIHQ Requirements for Patient Identification
    • CMS Critical Access Hospital Recertification Checklist for Evaluation of Compliance with the Location and Distance Requirements
    • Abbott Issues Voluntary Safety Notice on MitraClip Delivery System Deployment Process
    • Cook Medical Expands Recall for Beacon Tip Angiographic Catheters to Include Additional Product Lots
    • FDA Safety Communication – Neurosurgical Head Holders (Skull Clamps) Device Slippage
    • Joint Commission Issues Sentinel Event Alert 56 – Detecting and Treating Suicide Ideation in All Settings
    • CDC Issues Health Advisory with Updated Interim Recommendations for the Prevention of Sexual Transmission of Zika Virus
    • CDC Provides Summary of Zika Virus Infection (Zika)
    • FDA Warns Microbial Contamination in Syrspend SF and Syrspend SF Grape Suspending Agents by Fagron
    • Recall of Central Venous Catheters and Pressure Monitoring Sets and Trays by Cook Medical
    • Class I Recall of Oxylog 2000 Plus, 3000, and 3000 Plus Emergency Transport Ventilators by Dräger Medical
    • Unintended Retention of a Foreign Object Once Again Tops Joint Commission List of Most Frequently Reported Sentinel Events
    • FDA’s Automated Endoscope Reprocessors (AERs) Validation Testing
    • CDC Releases 2016 Childhood, Preteen, Teen and Adult Immunization Schedules
    • OSHA Reminds Employers to Post OSHA Form 300A
    • Joint Commission Publishes Prepublication Standards for Opioid Treatment Programs, Effective July 1, 2016
    • Customer Reviews
    • New USP Standard, Hazardous Drugs – Handling in Healthcare Settings, Effective July 1, 2018
    • CDC Interim Guidance for Care and Treatment of Pregnant Women during Zika Virus Outbreak
    • CDC Issues Health Advisory about Increased Influenza Activity
    • Class I Recall of SPOTCHEM II Test Strips by Arkray – Inaccurate Blood Sugar Readings
    • CDC Issues Health Advisory Urging Dialysis Providers and Facilities to Assess and Improve Infection Control Practices to Stop Hepatitis C Virus Transmission in Patients Undergoing Hemodialysis
    • Class I Recall of Thornhill Research Inc., MOVES Ventilator System
    • Recall of Baxter IV Solutions (Select Lots) – Potential for Leaking Containers and Particulate Matter
    • CMS Releases Guide to Preventing Readmissions among Racially and Ethnically Diverse Medicare Beneficiaries
    • Class I Recall of Optisure Dual Coil Defibrillation Leads by St. Jude Medical
    • New Study Raises Concerns about Ambulatory Care Nurses’ Infection Control Practices
    • CDC Adds Countries to Interim Travel Guidance Related to Zika Virus
    • Medical Device Reporting Requirements
    • US Senate Report Finds Fault with Hospitals Reporting Processes during Outbreak of Infections Linked to Medical Scopes
    • CDC Issues Health Advisory about Recognizing, Managing, and Reporting Zika Virus Infections in Travelers Returning from Central America, South America, the Caribbean, and Mexico
    • Recall of Unexpired Sterile Human and Animal Compounded Products by Abbott’s Compounding Pharmacy
    • New TJC Standards for Behavioral Health Care Organizations that Provide Outpatient or Residential Eating Disorder Programs
    • CMA Issues Guidance about Advance Care Planning (ACP) as an Optional Element of an Annual Wellness Visit (AWV)
    • Recall of Children’s Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company – Potential Defect with Dosage Cup
    • OCR Provides Guidance about Individuals’ Core Rights under HIPAA
    • Class I Recall of Pleural and Pneumopericardial Drainage Sets by Stryker Fuhrman
    • Joint Commission Seeks Comment on Draft Performance Measures for Total Hip & Total Knee Replacement
    • Recall of L.G Compounded Asafoetida Powder by Shakti Group – Potential Contamination with Salmonella
    • Second Phase of the Joint Commission’s National Patient Safety Goal (NPSG.06.01.01) is Now Effective
    • Class I Recall of Optional PS500 Batter Power Supply for Evita V500 and Babylog VN500 Ventilators by Dräger
    • Customer Reviews
    • CIHQ Requirements for Medication Orders
    • Recall of Baxter IV Solutions – Potential Presence of Particulate Matter
    • Pharmedium Issues Voluntary Nationwide Recall of 4mg Norepinephrine Bitartrate added to 0.9% Sodium Chloride in 250mL Viaflex Bag and 8mg Norepinephrine Bitartrate added to 0.9% Sodium Chloride in 250mL Viaflex Bag
    • FDA Issues Drug Safety Communication for Noxafil (posaconazole)
    • OSHA Seeks Comments on Updated Version of Voluntary Safety and Health Program Management Guidelines
    • CMS and ONC Issue Request for Information about Certification Frequency and Requirements for Reporting of Quality Measures
    • CMS Infection Control Pilot Project
    • Class I Recall: Etest PIP/TAZO/CON-4 PTC 256 by bioMérieux
    • CMS Finalizes Rule Creating Prior Authorization Process for Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies Items
    • Class I Recall of Boston Scientific Corporation’s Chariot Guiding Sheath
    • Class I Recall of Draeger Perseus A500 Anesthesia Workstation
    • Class I Recall of Insulet Corporation OmniPod Insulin Management System
    • FDA MedWatch – ED-530XT Duodenoscopes by FUJIFILM Medical Systems, U.S.A.: Safety Communication
    • FDA Updates Blood Donor Deferral Policy
    • New OSHA Website on Workplace Violence
    • Joint Commission Releases Prepublication Standards for New, Optional Total Hip and Total Knee Replacement Advanced Certification
    • FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS) for Rosiglitazone-containing Diabetes Medicines
    • Recall of Chariot Guiding Sheath by Boston Scientific
    • FDA Warns of Potential Contamination with Baclofen Active Pharmaceutical Ingredient from Taizhou Xinyou Pharmaceutical and Chemical
    • CMS Releases Focused Dementia Care Survey Tools
    • CDC Issues Guidance for Vaccine Providers about 2015-2016 Pentacel Manufacturing Delay
    • Class I Recall of Inspiration LS, 5i and 7i Ventilator Systems by eVent Medical
    • CMS Releases Compilation of ICD-10 Resources for Specialties and Selected Health ICD-10 Conditions and Services
    • Joint Commission Seeks Comments on Proposed New Standard on Antimicrobial Stewardship
    • Field Safety Notification for OmniPod Insulin Management System by Insulet
    • Recall of Digital Temple Thermometer (DTT) by K-Jump Health Co., Ltd.
    • Guide to Providing Effective Communication and Language Assistance Services
    • FDA Announces Glades Drugs’ Nationwide Voluntary Recall of Compounded Multivitamins Containing High Amounts of Vitamin D3
    • Class I Recall of Boston Scientific’s RotaWire Elite Guidewire and wireClip Torquer Guidewire
    • CIHQ Requirements for the Management of Radioactive Materials
    • CDC Urges Providers to Counsel Patients about HIV Pre-exposure Prophylaxis
    • FDA Issues Safety Communication for Intravascular Medical Devices
    • Essential Components of a Comprehensive Compliance Plan
    • CMS Issues Advanced Notice of Revised Survey Procedures and Interpretive Guidelines for Laboratories and Laboratory Services
    • FDA Drug Safety Communication about Iodine-containing Contrast Agents for Medical Imaging of Infants
    • FDA Orders Recall under Consent Decree for all Custom Ultrasonics Automated Endoscope Reprocessors
    • Joint Commission Releases 2016 National Patient Safety Goals
    • FDA Offers New MRI Safety Resource
    • Class I Recall of G5 Ventilator by Hamilton – Ventilation and Alarm Failure
    • Get Smart About Antibiotics Week
    • OIG 2016 Work Plan for Nursing Homes and Hospices
    • Office of Inspector General 2016 Work Plan – Medical Equipment and Supplies
    • OIG’s 2016 Work Plan for Hospitals
    • OIG’s 2016 Work Plan for Home Health
    • Comments Sought on Draft Guidance about Minutes of IRB Meetings
    • CDC Issues Challenge to Identify Best Practices for Healthcare-associated Blood Clot Prevention
    • Office of Inspector General Releases 2016 Work Plan
    • Joint Commission Warns that Temporary Names Put Newborns at Risk
    • Recall of Myocardial Protection System (MPS) Delivery Sets by Quest Medical
    • FDA Issues Revised Dispenser Compliance Policy – Extended to March 1, 2016
    • CMS Proposing Revisions to Discharge Planning Requirements
    • CIHQ Medical Record Entry Requirements
    • FDA Updates Drug Safety Communication for Stalevo
    • CDC Issues Health Advisory about Increases in Fentanyl Drug Confiscations and Fentanyl-related Overdose Fatalities
    • Drug Safety Communication for Viekira Pak and Technivie
    • New Apps – Fresh Ideas
    • Dave Gardner
    • Dave Gardner
    • Tech Conference 2015
    • Interview With CEO
    • App’s Update Reaches More Customers
    • New Trends In Responsive Design
    • CDC Launches Improved Online Foodborne Outbreak Search Tool
    • Recall of Downing Labs, LLC Sterile Compounded Products for Lack of Sterility Assurance
    • Dialysis Infection Prevention and Control – Patient Education
    • Preliminary Results of Study into Persistence of Ebola Virus in Body Fluids
    • CDC Study Shows Urgent Need for Improved Controlled Substance Prescribing Practices
    • Reporting Vaccine Adverse Events
    • FDA Issues Safety Communication about Nontuberculous Mycobacterium Infections Associated with Heater-Cooler Devices
    • Cook Medical Expands Global Recall of Select Sizes of Beacon Tip Angiographic Catheters
    • Rapid Diagnostic Testing for Influenza
    • Influenza Vaccine Composition for 2015-2016 U.S. Influenza Season
    • OIG Issues Policy Reminder about Information Blocking and the Federal Anti-Kickback Statute
    • HHS’ OCR New mHealth Platform Aids Developers with HIPAA Questions
    • FDA Notification about Bioprosthetic Aortic Valves
    • FDA’s Drug Supply Chain Security Act Enforcement Date Approaching
    • CDC and FDA Issue Health Update about the Immediate Need for Healthcare Facilities to Review Procedures for Cleaning, Disinfecting, and Sterilizing Medical Devices
    • CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines
    • CDC Ends Enhanced Entry Screening For Travelers from Liberia
    • Joint Commission Issues Sentinel Event Alert #55 – Preventing Falls and Fall-Related Injuries in Health Care Facilities
    • FDA Safety Communication – Cranial Perforators with an Automatic Clutch Mechanism, Failure to Disengage
    • Key Points from the Secure and Responsible Drug Disposal Act of 2010
    • Recall of Sterile Compounded Products by US Compounding, Inc.
    • Joint Commission Removes Life Safety Chapter from their Office Based Surgery Practices Manual – Effective Immediately
    • EPA Proposes Management Standards for Hazardous Waste Pharmaceuticals
    • Tech Magazine Writes About Digital Trends
    • Designing The App Of The Future
    • Tips On Managing Business
    • Tips On Managing Business
    • Katrina Thornton
    • Katrina Thornton
    • FDA Drug Safety Communication about Avycaz (ceftazidime and avibactam)
    • New CDC Antibiotic Stewardship Recommendations for Nursing Homes
    • Class I Recall of SynCardia Systems Freedom Driver System
    • FDA Safety Communication about Infections Associated with Reprocessed Flexible Bronchoscopes
    • Thoratec Issues Voluntary Device Correction
    • FDA Issues Drug Safety Communication for Clozapine
    • AHRQ New Patient Safety Primer – High Reliability
    • Interview With CFO of Fashion Startup
    • Managing Office Culture
    • New Trends In Responsive Design
    • New News App Deliveres Fresh Ideas
    • Class I Recall of Cook Medical’s Beacon Tip Angiographic Catheters – Catheter Tip May Slip or Separate
    • National Cybersecurity Center of Excellence (NCCoE) Seeks Comments on Draft Cybersecurity Practice Guide
    • CMS Memorandum about Medication-Related Adverse Events in Nursing Homes
    • CMS Issues Clarifying Questions and Answers Regarding ICD-10 Flexibilities
    • FDA Drug Safety Communication on Gilenya
    • FDA Safety Communication – Supplemental Measures to Enhance Duodenoscope Reprocessing
    • FDA Safety Communication – Symbiq Infusion System by Hospira: Cybersecurity Vulnerabilities
    • Brintellix (vortioxetine) and Brilinta (ticagrelor) – Name Confusion
    • Hospira Recalling 21 Million Units of Three Injectables
    • CMS Updates Ambulatory Surgical Center (ASC) Infection Control Surveyor Worksheet
    • Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (Fluorouracil Injection, USP)
    • Charlie French
    • Tech Conference 2015
    • Interview With CEO Of Big Data Startup
    • Best Practices for Prevention Slips, Trips and Falls in the Workplace
    • Best Practices for Workplace Violence Prevention
    • FDA Issues Drug Safety Communication for NSAIDs
    • CMS Issues Proposed Physician Fee Schedule for Calendar Year 2016
    • Critical Components of a Safe Patient Handling Program
    • Joint Commission Seeks Input on Two New Proposed Behavioral Health Care Standards
    • FDA Warns Consumers of Risks with Diazepam – Potential of Counterfeit
    • Class I Recall of Teleflex Hudson RCI Lifesaver Single Patient Use Manual Resuscitator
    • Class I Recall of FLOW-i Anesthesia Systems by Maquet
    • FDA Warns of Unapproved Prescription Ear Drop (Otic) Products
    • FDA Drug Safety Communication – Potential Risks of Using Codeine Cough-and-Cold Medicines in Children
    • HHS Launches National Ebola Training and Education Center
    • FDA Announces Delay in Enforcement for Drug Supply Chain Security Act
    • OSHA Adds Key Hazards for Investigators’ Focus during Healthcare Inspections
    • HHS Interactive Online emPOWER Map Available
    • Joint Commission Expands Threshold for Reporting Perinatal Care Measure Set
    • Recall of Covidien Shiley Neonatal and Pediatric Tracheostomy Tubes by Medtronic
    • CDC Health Advisory – Evaluation of Ill Travelers from Liberia to the United States
    • Joseph Turner
    • Interview With CFO of Fashion Startup
    • Class I Recall of M/L Taper with Kinectiv Technology Prosthesis by Zimmer
    • Managing Office Culture
    • International Operation Pangea VIII
    • CDC’s NIOSH Releases Research Findings on N95 Respirator Use by Pregnant Women
    • Class I Recall of HeartWare Ventricular Assist System
    • CMS Issues Guidance for Approval of Home Dialysis Modalities
    • CDC Health Advisory Regarding Updated Information and Guidelines for Evaluation of Patients for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection
    • Joint Commission Seeks Comment on Proposed Comprehensive Cardiac Center Certification Requirements
    • The Joint Commission Revises Hospice Standards, Effective July 1, 2015
    • Mylan is Expanding its Voluntary Nationwide Recall of Select Lots of Injectable Products – Presence of Particulate Matter
    • CMS Releases New Clinical Laboratory Improvement Amendment’s (CLIA) Workbook
    • CDC Issues Health Advisory about Ciprofloxacin- and Azithromycin-Nonsusceptible Shigellosis in the United States
    • Voluntary Recall of Smart Lipo Due to Undeclared Sibutramine, Desmethylsibutramine, and Phenolphthalein
    • Voluntary Recall of Smart Lipo Due to Undeclared Sibutramine, Desmethylsibutramine, and Phenolphthalein
    • Baxter Initiates Voluntary Recall of Select Product Codes of Peripheral Vascular Patch
    • AHRQ Opens Data Submission for Annual Hospital Survey
    • TJC Revised Hospice Standards, Effective July 1, 2015
    • Fiscal Year 2015 HHS OIG Work Plan Mid-Year Update is Released
    • FDA Safety Communication – Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face
    • Recall of Avea Ventilator by CareFusion – Potential Malfunction of Pressure Transducer
    • The Joint Commission – Key Elements of a Fall Reduction Program
    • Tech Magazine Writes About Digital Trends
    • Designing The App Of The Future
    • UX Design Aimed At Millenials
    • Tech Conference 2017
    • Justin Pearson
    • Amanda Mills
    • CHA – Vail, CO – 9/10
    • HAP – Lancaster, PA – 9/9-9/10
    • Leadership Summit – San Francisco, CA – 7/23-7/24
    • CIHQ – Anaheim, CA – 6/10-6/11
    • MCN Learning: Quality of Life
MCN Solutions: Site Footer Logo

Contact Us

501 South Cherry Street

Suite 1100-106, Denver, CO 80246

Telephone: 800.538.6264

International: +1 303.762.0778

Fax: 303.762.0774

Important Links

Privacy Policy

MCN Foundation

Careers

Disclaimer

Web Accessibility

Site Map

dashicons-facebook-alt dashicons-twitter dashicons-linkedin dashicons-youtube

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Copyright 2025 MCN Solutions. All Rights Reserved. Designed by TinyFrog Technologies.